Does Antisynthetase Syndrome Increase the Risk of Cancer?

Yes, antisynthetase syndrome (ASyS) is associated with a slightly elevated risk of cancer compared to the general population, although this risk is generally lower than in other forms of adult idiopathic inflammatory myopathies (IIM—a group of rare immune diseases that cause muscle and skin inflammation), such as dermatomyositis ^[1]. It is important to know that most people with ASyS will not develop cancer. However, because ASyS is sometimes thought of as a “lower-risk” condition, it is crucial not to skip your necessary baseline cancer workup or routine preventive screenings ^[2]. Research suggests the highest risk of cancer usually occurs within the first three years of your disease onset (when your symptoms first started) ^[3][4].

Understanding Your Individual Risk

A large review of multiple studies estimated that about 8.3% of people with ASyS were found to have a malignancy (cancer) over varying periods of follow-up, but this prevalence changes based on the patients’ ages and how long they were observed ^[5]. Your rheumatologist will look at several factors to determine your personal risk level:

• Older age and prior history: Being older (especially over 60) or having a previous personal history of cancer are the strongest validated risk factors for developing a malignancy with ASyS ^[6][7].
• Time since disease onset: In adult inflammatory myopathies, the risk of cancer is typically highest within the three years before or after the first onset of disease symptoms ^[3][8].
• Autoantibody subtype: Anti-Jo-1 is the most common autoantibody (an immune protein that attacks the body’s own tissues) in ASyS and is generally associated with a reduced cancer risk compared to other myositis antibodies ^[9][5]. Some small studies suggest that rare non-Jo-1 subtypes (such as anti-OJ) might carry a slightly higher risk, but the data is inconsistent ^[10][11]. Your antibody type is just one piece of the puzzle and cannot diagnose or rule out cancer on its own.
• Symptom presentation: Some exploratory research noted that cancer-associated ASyS cases sometimes presented with less severe muscle weakness and lower creatine kinase (CK—a blood marker of muscle injury) ^[6]. However, this is not a reliable screening tool. High CK does not mean you are cancer-free, and low CK does not mean you have cancer.

Baseline Workups and Cancer Screening Guidelines

International guidelines recommend that adults diagnosed with idiopathic inflammatory myopathies undergo a baseline cancer workup ^[4]. This is not a “one size fits all” process; the extent of testing is stratified by your individual risk.

Standard Age-Appropriate Screenings
First, every patient should stay fully up-to-date with routine, preventive cancer screenings recommended for their age, sex, anatomy, and family history ^[2]. You should talk to your primary care doctor about your country’s guidelines for breast, cervical, colorectal, and prostate cancer screening (for instance, utilizing HPV testing for cervical screening, or discussing whether a PSA blood test is right for you).

Basic Malignancy Workup
At the time of your ASyS diagnosis, guidelines suggest a basic screening panel ^[4]. This typically includes:

• A comprehensive physical examination.
• Basic laboratory blood tests (such as complete blood counts and inflammatory markers).
• A chest X-ray.
  (Note: Many ASyS patients will receive a High-Resolution CT, or HRCT, of the chest. This scan creates highly detailed images of the lungs and is primarily used to evaluate interstitial lung disease, though it can also spot lung abnormalities. It is not an automatic requirement just for cancer screening).

Enhanced Screening for Higher-Risk Patients
If you have high-risk features—such as older age, a prior history of cancer, or concerning clinical signs—your doctor might recommend “enhanced” screening ^[4]. This is clinician-directed and might involve:

• CT scans of the abdomen and pelvis ^[4].
• Tumor marker blood tests (proteins sometimes elevated in cancer, though they can have high false-positive rates) ^[4].
• A PET-CT scan (an advanced imaging test that highlights areas of high cellular activity), usually reserved for investigating suspicious symptoms like an atypical lung lesion or unexplained weight loss ^[12][4].

It is important to know that broad, whole-body imaging (like routine PET-CT or full-body CT) is not recommended for everyone. These tests carry risks, including radiation exposure, contrast risks, and false-positive results that can lead to unnecessary anxiety and invasive biopsies ^[13]. Enhanced testing is only used when your overall clinical risk warrants it. Your doctor will also tell you if you need to repeat any screenings annually for the first few years; there is no universal rule that every single patient needs yearly scans.

What to Watch For and When to Seek Urgent Care

While routine medical screening is vital, monitoring your own body is just as important. Discuss any unexplained weight loss, persistent fevers, night sweats, new localized pain, or abnormal bleeding with your doctor at your regular appointments ^[12][14].

Urgent Safety Warning: If you experience severe or rapidly worsening shortness of breath, sudden chest pain, blue lips, confusion, or markedly low oxygen levels, seek emergency medical care immediately. In ASyS, these are often signs of a severe lung flare, a blood clot, or an infection (especially since you are likely on immunosuppressive medications), rather than just cancer. Never stop or change your immunosuppressive treatments because of cancer concerns without speaking to your specialist first.